Ftse Mib
36.200,72
0,24%
DAX
21.394,93
-0,11%
S&P 500
6.101,24
-0,29%
NASDAQ
19.954,30
-0,50%
Bitcoin
101.033,74
-1,59%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Personalis Inc (PSNL) Personalis Inc (PSNL) Notizie

Personalis Inc

PSNL
6,05
-0,10 (-1,63%)
25 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/1/202511:00BWNew Nature Medicine Publication Shows ctDNA Levels Linked to..
11/1/202503:20EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
07/1/202522:36EDGAR2Form 8-K - Current report
07/1/202522:01BWPersonalis Reports Preliminary Fourth Quarter and Full Year..
27/12/202422:07EDGAR2Form 8-K - Current report
27/12/202422:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/12/202415:06EDGAR2Form 8-K - Current report
19/12/202415:00BWPersonalis Advances Business Strategy with Investment from..
18/12/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202414:00BWPersonalis and Tempus Expand Collaboration to Biopharma
20/11/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202422:01BWPersonalis to Participate at Upcoming Investor Conferences
06/11/202422:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202422:01BWPersonalis Reports Third Quarter 2024 Financial Results
06/11/202422:00EDGAR2Form 8-K - Current report
05/11/202422:01BWPersonalis to Present at the Stifel 2024 Healthcare..
23/10/202422:01BWPersonalis to Announce Third Quarter 2024 Financial Results
19/9/202423:28EDGAR2Form 8-K - Current report
16/9/202415:00BWESMO 2024 Data Expands on Compelling Performance of..
30/8/202422:43EDGAR2Form S-3 - Registration statement under Securities Act of..
22/8/202422:01BWPersonalis to Participate at Upcoming Investor Conferences
20/8/202422:27EDGAR2Form SC 13D/A - General Statement of Acquisition of..
20/8/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202422:05BWPersonalis Announces Inducement Grants Under Nasdaq Listing..
16/8/202415:25EDGAR2Form 8-K - Current report
16/8/202414:30BWPersonalis and Tempus Announce Expanded Collaboration
07/8/202422:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202422:01BWPersonalis Reports Second Quarter 2024 Financial Results
07/8/202422:00EDGAR2Form 8-K - Current report
06/8/202422:05GLOBEMyriad Genetics Reports Strong Second Quarter 2024 Financial..
01/8/202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202422:01BWPersonalis to Participate at the 9th Annual Needham Virtual..
24/7/202422:01BWPersonalis to Announce Second Quarter 2024 Financial Results
11/7/202415:00GLOBEMyriad Genetics and Personalis Cross-License Foundational..
18/6/202422:01BWPersonalis to Participate at the TD Cowen 3rd Annual Tools /..
13/6/202414:00BWPersonalis Provides Dial-in and Updated Date for ASCO..
04/6/202422:05BWASCO Data Highlights NeXT Personal® Ultra-sensitive MRD..
31/5/202415:05BWPersonalis Announces Start of Cancer MRD Testing..
22/5/202415:05BWPersonalis Announces Podium Presentations and Abstracts..
22/5/202403:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202403:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202422:12EDGAR2Form 8-K - Current report
17/5/202422:05BWPersonalis Announces Inducement Grants Under Nasdaq Listing..
08/5/202422:01BWPersonalis Reports First Quarter 2024 Financial Results
08/5/202422:00EDGAR2Form 8-K - Current report
24/4/202422:01BWPersonalis to Announce First Quarter 2024 Financial Results
28/3/202421:01BWPersonalis to Present at the 23rd Annual Needham Virtual..
28/3/202414:00BWData Showcasing NeXT Personal MRD Test to be Presented at..
Apertura: 6,27 Min: 5,92 Max: 6,2737
Chiusura: 6,15

La tua Cronologia

NASDAQ
PSNL
Personalis
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network